(Alliance News) - The UK pub sector awaits a GBP100 million support package from the Treasury aimed at easing cost pressures, the Financial Times reports, while Sage posts 10% quarterly revenue growth and Dr Martens reports a dip in third-quarter revenue. Read More
(Alliance News) - HSBC Holdings Chair Brendan Nelson is among senior business figures set to travel to China with UK Prime Minister Keir Starmer next week, as the government seeks to reset relations with Beijing, Sky News reported on Thursday. Read More
(Alliance News) - Daiichi Sankyo Co Ltd and AstraZeneca PLC on Thursday said Chinese regulators have approved their jointly developed drug Enhertu to treat gastric cancer. Read More
(Alliance News) - The FTSE 100 shrugged off a weak start to close slightly higher on Wednesday after US President Donald Trump said he would not use force to take control of Greenland, but insisted the US must still have "ownership" of it. Read More
(Alliance News) - The UK and China will seek to re-establish a business dialogue of top executives during UK Prime Minister Keir Starmer's widely-expected visit to Beijing, Reuters reported Wednesday. Read More
(Alliance News) - Stock prices in London were lower at midday on Tuesday, as the ongoing tension between the US and Europe over Greenland rattled investor sentiment. Read More
AstraZeneca PLC - Cambridge, England-based pharmaceuticals maker - Expects its shares to start trading directly on the New York Stock Exchange from Monday, February 2. This will follow Astra's American depositary shares being delisted from Nasdaq on the Friday before, January 30. Astra says the direct US listing, which it first announced in September, will "deliver a global listing for global investors in a global company". Astra's shares will remain tradable on the London Stock Exchange and Nasdaq Stockholm, and it will retain its FTSE 100 index membership. Its ticker symbol will remain 'AZN'. Read More
(Alliance News) - Daiichi Sanyko Co Ltd on Monday said EU regulators had validated an application for its breast cancer treatment, Enhertu with pertuzumab, jointly developed with AstraZeneca PLC. Read More
(Alliance News) - The following London-listed shares received analyst recommendations Friday morning and on Thursday: Read More
(Alliance News) - Stock prices in London closed higher on Thursday, after a surprise drop in US jobless claims. Read More
(Alliance News) - Hutchmed China Ltd on Wednesday said the results from its SACHI phase-three lung cancer trial have been published in medical journal the Lancet. Read More
(Alliance News) - Stock prices in London were mixed at midday on Wednesday, as gains among miners lifted the FTSE 100. Read More
(Alliance News) - Polar Capital Global Healthcare Trust PLC on Wednesday said demand for healthcare products remains robust as it outperformed its benchmark. Read More
(Alliance News) - UK Business Secretary Peter Kyle is set to tell the heads of top firms that he will "fight tooth and nail" to achieve US levels of economic growth. Read More
(Alliance News) - The following London-listed shares received analyst recommendations Wednesday morning and on Tuesday: Read More
(Alliance News) - Blue chips continued their strong start to the year on Tuesday with the FTSE 100 hitting a new record led by gains in retailer Next and drug stocks, GSK and AstraZeneca. Read More
(Alliance News) - AstraZeneca PLC on Tuesday said a Saphnelo self-administration Thlip-SC trial demonstrated statistically significant and clinically meaningful reduction in systemic lupus erythematosus disease activity. Read More
(Alliance News) - Hutchmed China Ltd on Tuesday said Chinese regulators have accepted and granted priority review to its new drug application for savolitinib to treat certain patients with advanced gastric cancer, marking another regulatory step forward for the targeted therapy. Read More
(Alliance News) - The FTSE 100 drifted lower on Wednesday in lacklustre trading ahead of the Christmas break, although a chunky disposal by BP brought some life to proceedings. Read More
(Alliance News) - Stock prices in London opened modestly lower on Wednesday, during a shortened trading session ahead of the Christmas holiday break. Read More